Report Detail
Global Anticonvulsants Market Professional Survey Report 2019
- RnM3810288 |
- 09 October, 2019 |
- Global |
- 101 Pages |
- QYResearch |
- Pharma & Healthcare
The Anticonvulsants are the diverse group of the pharmacological agents used in the treatment of epileptic seizures. Anticonvulsants are also increasingly being used in the treatment of bipolar disorder and borderline personality disorder. They seem to act as mood stabilizers, and for the treatment of neuropathic pain. Anticonvulsants suppress the rapid and excessive firing of neurons during seizures. Anticonvulsants also prevent the spread of the seizure within the brain.
Anticonvulsant drugs are primarily developed for the treatment of epilepsy, a neurological condition that affects around the 50 million people worldwide. They reduce seizure frequency by suppressing neuronal excitability via various molecular targets in the synapse, including voltage-gated ion channels, voltage-gated GABAA (γ-aminobutyric acid type A) receptors and glutamate receptors.
The global Anticonvulsants market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anticonvulsants volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anticonvulsants market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anticonvulsants in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anticonvulsants manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Johnson & Johnson (J&J)
Novartis AG
UCB Group
GlaxoSmithKline plc.
Pfizer Inc.
Abbott Laboratories
Cephalon Inc.
Shire plc.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Epilepsy
Fibromyalgia
Migraine
Neuropathic pain
Bipolar disorder
Anxiety
Borderline personality disorder
Segment by Application
Hospital
Clinic
Home Care
Table of Contents
Executive Summary
1 Industry Overview of Anticonvulsants
- 1.1 Definition of Anticonvulsants
- 1.2 Anticonvulsants Segment by Type
- 1.2.1 Global Anticonvulsants Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Epilepsy
- 1.2.3 Fibromyalgia
- 1.2.4 Migraine
- 1.2.5 Neuropathic pain
- 1.2.6 Bipolar disorder
- 1.2.7 Anxiety
- 1.2.8 Borderline personality disorder
- 1.3 Anticonvulsants Segment by Applications
- 1.3.1 Global Anticonvulsants Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Home Care
- 1.4 Global Anticonvulsants Overall Market
- 1.4.1 Global Anticonvulsants Revenue (2014-2025)
- 1.4.2 Global Anticonvulsants Production (2014-2025)
- 1.4.3 North America Anticonvulsants Status and Prospect (2014-2025)
- 1.4.4 Europe Anticonvulsants Status and Prospect (2014-2025)
- 1.4.5 China Anticonvulsants Status and Prospect (2014-2025)
- 1.4.6 Japan Anticonvulsants Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Anticonvulsants Status and Prospect (2014-2025)
- 1.4.8 India Anticonvulsants Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Anticonvulsants
- 2.3 Manufacturing Process Analysis of Anticonvulsants
- 2.4 Industry Chain Structure of Anticonvulsants
3 Development and Manufacturing Plants Analysis of Anticonvulsants
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Anticonvulsants Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Anticonvulsants
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Anticonvulsants Production and Capacity Analysis
- 4.2 Anticonvulsants Revenue Analysis
- 4.3 Anticonvulsants Price Analysis
- 4.4 Market Concentration Degree
5 Anticonvulsants Regional Market Analysis
- 5.1 Anticonvulsants Production by Regions
- 5.1.1 Global Anticonvulsants Production by Regions
- 5.1.2 Global Anticonvulsants Revenue by Regions
- 5.2 Anticonvulsants Consumption by Regions
- 5.3 North America Anticonvulsants Market Analysis
- 5.3.1 North America Anticonvulsants Production
- 5.3.2 North America Anticonvulsants Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Anticonvulsants Import and Export
- 5.4 Europe Anticonvulsants Market Analysis
- 5.4.1 Europe Anticonvulsants Production
- 5.4.2 Europe Anticonvulsants Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Anticonvulsants Import and Export
- 5.5 China Anticonvulsants Market Analysis
- 5.5.1 China Anticonvulsants Production
- 5.5.2 China Anticonvulsants Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Anticonvulsants Import and Export
- 5.6 Japan Anticonvulsants Market Analysis
- 5.6.1 Japan Anticonvulsants Production
- 5.6.2 Japan Anticonvulsants Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Anticonvulsants Import and Export
- 5.7 Southeast Asia Anticonvulsants Market Analysis
- 5.7.1 Southeast Asia Anticonvulsants Production
- 5.7.2 Southeast Asia Anticonvulsants Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Anticonvulsants Import and Export
- 5.8 India Anticonvulsants Market Analysis
- 5.8.1 India Anticonvulsants Production
- 5.8.2 India Anticonvulsants Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Anticonvulsants Import and Export
6 Anticonvulsants Segment Market Analysis (by Type)
- 6.1 Global Anticonvulsants Production by Type
- 6.2 Global Anticonvulsants Revenue by Type
- 6.3 Anticonvulsants Price by Type
7 Anticonvulsants Segment Market Analysis (by Application)
- 7.1 Global Anticonvulsants Consumption by Application
- 7.2 Global Anticonvulsants Consumption Market Share by Application (2014-2019)
8 Anticonvulsants Major Manufacturers Analysis
- 8.1 Johnson & Johnson (J&J)
- 8.1.1 Johnson & Johnson (J&J) Anticonvulsants Production Sites and Area Served
- 8.1.2 Johnson & Johnson (J&J) Product Introduction, Application and Specification
- 8.1.3 Johnson & Johnson (J&J) Anticonvulsants Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Novartis AG
- 8.2.1 Novartis AG Anticonvulsants Production Sites and Area Served
- 8.2.2 Novartis AG Product Introduction, Application and Specification
- 8.2.3 Novartis AG Anticonvulsants Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 UCB Group
- 8.3.1 UCB Group Anticonvulsants Production Sites and Area Served
- 8.3.2 UCB Group Product Introduction, Application and Specification
- 8.3.3 UCB Group Anticonvulsants Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 GlaxoSmithKline plc.
- 8.4.1 GlaxoSmithKline plc. Anticonvulsants Production Sites and Area Served
- 8.4.2 GlaxoSmithKline plc. Product Introduction, Application and Specification
- 8.4.3 GlaxoSmithKline plc. Anticonvulsants Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Pfizer Inc.
- 8.5.1 Pfizer Inc. Anticonvulsants Production Sites and Area Served
- 8.5.2 Pfizer Inc. Product Introduction, Application and Specification
- 8.5.3 Pfizer Inc. Anticonvulsants Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Abbott Laboratories
- 8.6.1 Abbott Laboratories Anticonvulsants Production Sites and Area Served
- 8.6.2 Abbott Laboratories Product Introduction, Application and Specification
- 8.6.3 Abbott Laboratories Anticonvulsants Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Cephalon Inc.
- 8.7.1 Cephalon Inc. Anticonvulsants Production Sites and Area Served
- 8.7.2 Cephalon Inc. Product Introduction, Application and Specification
- 8.7.3 Cephalon Inc. Anticonvulsants Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Shire plc.
- 8.8.1 Shire plc. Anticonvulsants Production Sites and Area Served
- 8.8.2 Shire plc. Product Introduction, Application and Specification
- 8.8.3 Shire plc. Anticonvulsants Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Anticonvulsants Market
- 9.1 Global Anticonvulsants Market Trend Analysis
- 9.1.1 Global Anticonvulsants Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Anticonvulsants Regional Market Trend
- 9.2.1 North America Anticonvulsants Forecast 2019-2025
- 9.2.2 Europe Anticonvulsants Forecast 2019-2025
- 9.2.3 China Anticonvulsants Forecast 2019-2025
- 9.2.4 Japan Anticonvulsants Forecast 2019-2025
- 9.2.5 Southeast Asia Anticonvulsants Forecast 2019-2025
- 9.2.6 India Anticonvulsants Forecast 2019-2025
- 9.3 Anticonvulsants Market Trend (Product Type)
- 9.4 Anticonvulsants Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Anticonvulsants Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Anticonvulsants. Industry analysis & Market Report on Anticonvulsants is a syndicated market report, published as Global Anticonvulsants Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Anticonvulsants market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
